CUAMC
ARTV

China Universal Asset Management Company’s Artiva Biotherapeutics ARTV Stock Holding History

China Universal Asset Management Company’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Buy
+1,600
New +$14.6K ﹤0.01% 500
2025
Q4 		– Sell
-4,281
Closed -$12.3K – 540
2025
Q3 		$12.3K Sell
4,281
-612
-13% -$1.64K ﹤0.01% 470
2025
Q2 		$7.39K Buy
4,893
+21
+0.4% +$44 ﹤0.01% 470
2025
Q1 		$14.6K Sell
4,872
-278
-5% -$1.5K ﹤0.01% 466
2024
Q4 		$51.9K Buy
+5,150
New +$61.9K ﹤0.01% 450

Other funds holding ARTV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

China Universal Asset Management Company's ARTV Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Artiva Biotherapeutics (ARTV) in Q2 2026: 1,600 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #500 among its holdings. This is a return to the name: China Universal Asset Management Company previously reported a position in ARTV as recently as Q3 2025.

China Universal Asset Management Company first reported a position in ARTV in Q4 2024 and has held it in 5 quarters since. The position peaked at $51.9K in Q4 2024. 12 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • China Universal Asset Management Company held 1,600 shares of Artiva Biotherapeutics worth $15.5K as of Q2 2026.
  • Artiva Biotherapeutics was a new China Universal Asset Management Company position in Q2 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #500 holding.
  • China Universal Asset Management Company first reported a position in Artiva Biotherapeutics in Q4 2024 and has held it in 5 quarters since.
  • China Universal Asset Management Company's Artiva Biotherapeutics position peaked at $51.9K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.